Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Pharm Biopharm ; 189: 68-83, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37196871

ABSTRACT

Development and manufacturing adeno-associated virus (AAV)-based vectors for gene therapy requires suitable analytical methods to assess the quality of the formulations during development, as well as the quality of different batches and the consistency of the processes. Here, we compare biophysical methods to characterize purity and DNA content of viral capsids from five different serotypes (AAV2, AAV5, AAV6, AAV8, and AAV9). For this purpose, we apply multiwavelength sedimentation velocity analytical ultracentrifugation (SV-AUC) to obtain the species' contents and to derive the wavelength-specific correction factors for the respective insert-size. In an orthogonal manner we perform anion exchange chromatography (AEX) and UV-spectroscopy and the three methods yield comparable results on empty/filled capsid contents with these correction factors. Whereas AEX and UV-spectroscopy can quantify empty and filled AAVs, only SV-AUC could identify the low amounts of partially filled capsids present in the samples used in this study. Finally, we employ negative-staining transmission electron microscopy and mass photometry to support the empty/filled ratios with methods that classify individual capsids. The obtained ratios are consistent throughout the orthogonal approaches as long as no other impurities and aggregates are present. Our results show that the combination of selected orthogonal methods can deliver consistent empty/filled contents on non-standard genome sizes, as well as information on other relevant critical quality attributes, such as AAV capsid concentration, genome concentration, insert size length and sample purity to characterize and compare AAV preparations.


Subject(s)
Capsid , Dependovirus , Dependovirus/genetics , Dependovirus/chemistry , Genetic Vectors , Capsid Proteins , Ultracentrifugation , DNA
2.
Sci Rep ; 8(1): 5171, 2018 03 26.
Article in English | MEDLINE | ID: mdl-29581527

ABSTRACT

MIF is a chemokine-like cytokine that plays a role in the pathogenesis of inflammatory and cardiovascular disorders. It binds to the chemokine-receptors CXCR2/CXCR4 to trigger atherogenic leukocyte migration albeit lacking canonical chemokine structures. We recently characterized an N-like-loop and the Pro-2-residue of MIF as critical molecular determinants of the CXCR4/MIF binding-site and identified allosteric agonism as a mechanism that distinguishes CXCR4-binding to MIF from that to the cognate ligand CXCL12. By using peptide spot-array technology, site-directed mutagenesis, structure-activity-relationships, and molecular docking, we identified the Arg-Leu-Arg (RLR) sequence-region 87-89 that - in three-dimensional space - 'extends' the N-like-loop to control site-1-binding to CXCR4. Contrary to wildtype MIF, mutant R87A-L88A-R89A-MIF fails to bind to the N-terminal of CXCR4 and the contribution of RLR to the MIF/CXCR4-interaction is underpinned by an ablation of MIF/CXCR4-specific signaling and reduction in CXCR4-dependent chemotactic leukocyte migration of the RLR-mutant of MIF. Alanine-scanning, functional competition by RLR-containing peptides, and molecular docking indicate that the RLR residues directly participate in contacts between MIF and CXCR4 and highlight the importance of charge-interactions at this interface. Identification of the RLR region adds important structural information to the MIF/CXCR4 binding-site that distinguishes this interface from CXCR4/CXCL12 and will help to design MIF-specific drug-targeting approaches.


Subject(s)
Intramolecular Oxidoreductases/genetics , Macrophage Migration-Inhibitory Factors/genetics , Protein Binding/genetics , Receptors, CXCR4/genetics , Structure-Activity Relationship , Binding Sites , Cardiovascular Diseases/genetics , Cardiovascular Diseases/pathology , Chemotaxis/genetics , Humans , Inflammation/genetics , Inflammation/pathology , Intramolecular Oxidoreductases/chemistry , Ligands , Macrophage Migration-Inhibitory Factors/chemistry , Molecular Docking Simulation , Peptides/chemistry , Peptides/genetics , Receptors, CXCR4/chemistry , Receptors, Interleukin-8B/chemistry , Receptors, Interleukin-8B/genetics
3.
J Biol Chem ; 292(35): 14587-14602, 2017 09 01.
Article in English | MEDLINE | ID: mdl-28684415

ABSTRACT

The interaction of the intrinsically disordered polypeptide islet amyloid polypeptide (IAPP), which is associated with type 2 diabetes (T2D), with the Alzheimer's disease amyloid-ß (Aß) peptide modulates their self-assembly into amyloid fibrils and may link the pathogeneses of these two cell-degenerative diseases. However, the molecular determinants of this interaction remain elusive. Using a systematic alanine scan approach, fluorescence spectroscopy, and other biophysical methods, including heterocomplex pulldown assays, far-UV CD spectroscopy, the thioflavin T binding assay, transmission EM, and molecular dynamics simulations, here we identified single aromatic/hydrophobic residues within the amyloid core IAPP region as hot spots or key residues of its cross-interaction with Aß40(42) peptide. Importantly, we also find that none of these residues in isolation plays a key role in IAPP self-assembly, whereas simultaneous substitution of four aromatic/hydrophobic residues with Ala dramatically impairs both IAPP self-assembly and hetero-assembly with Aß40(42). Furthermore, our experiments yielded several novel IAPP analogs, whose sequences are highly similar to that of IAPP but have distinct amyloid self- or cross-interaction potentials. The identified similarities and major differences controlling IAPP cross-peptide interaction with Aß40(42) versus its amyloid self-assembly offer a molecular basis for understanding the underlying mechanisms. We propose that these insights will aid in designing intervention strategies and novel IAPP analogs for the management of type 2 diabetes, Alzheimer's disease, or other diseases related to IAPP dysfunction or cross-amyloid interactions.


Subject(s)
Amino Acids/metabolism , Amyloid beta-Peptides/metabolism , Islet Amyloid Polypeptide/metabolism , Models, Molecular , Peptide Fragments/metabolism , Protein Aggregation, Pathological/metabolism , Amino Acid Substitution , Amino Acids/chemistry , Amino Acids, Aromatic , Amyloid beta-Peptides/chemical synthesis , Amyloid beta-Peptides/chemistry , Circular Dichroism , Humans , Hydrophobic and Hydrophilic Interactions , Islet Amyloid Polypeptide/chemical synthesis , Islet Amyloid Polypeptide/chemistry , Kinetics , Methylation , Microscopy, Electron, Transmission , Molecular Dynamics Simulation , Peptide Fragments/chemical synthesis , Peptide Fragments/chemistry , Protein Stability , Protein Structure, Secondary , Solid-Phase Synthesis Techniques , Solubility , Spectrometry, Fluorescence
4.
J Biol Chem ; 291(30): 15881-95, 2016 Jul 22.
Article in English | MEDLINE | ID: mdl-27226569

ABSTRACT

An emerging number of non-chemokine mediators are found to bind to classical chemokine receptors and to elicit critical biological responses. Macrophage migration inhibitory factor (MIF) is an inflammatory cytokine that exhibits chemokine-like activities through non-cognate interactions with the chemokine receptors CXCR2 and CXCR4, in addition to activating the type II receptor CD74. Activation of the MIF-CXCR2 and -CXCR4 axes promotes leukocyte recruitment, mediating the exacerbating role of MIF in atherosclerosis and contributing to the wealth of other MIF biological activities. Although the structural basis of the MIF-CXCR2 interaction has been well studied and was found to engage a pseudo-ELR and an N-like loop motif, nothing is known about the regions of CXCR4 and MIF that are involved in binding to each other. Using a genetic strain of Saccharomyces cerevisiae that expresses a functional CXCR4 receptor, site-specific mutagenesis, hybrid CXCR3/CXCR4 receptors, pharmacological reagents, peptide array analysis, chemotaxis, fluorescence spectroscopy, and circular dichroism, we provide novel molecular information about the structural elements that govern the interaction between MIF and CXCR4. The data identify similarities with classical chemokine-receptor interactions but also provide evidence for a partial allosteric agonist compared with CXCL12 that is possible due to the two binding sites of CXCR4.


Subject(s)
Chemokine CXCL12 , Intramolecular Oxidoreductases , Macrophage Migration-Inhibitory Factors , Receptors, CXCR4 , Allosteric Regulation , Animals , CHO Cells , Chemokine CXCL12/chemistry , Chemokine CXCL12/genetics , Chemokine CXCL12/metabolism , Cricetinae , Cricetulus , Humans , Intramolecular Oxidoreductases/chemistry , Intramolecular Oxidoreductases/genetics , Intramolecular Oxidoreductases/metabolism , Macrophage Migration-Inhibitory Factors/chemistry , Macrophage Migration-Inhibitory Factors/genetics , Macrophage Migration-Inhibitory Factors/metabolism , Receptors, CXCR4/chemistry , Receptors, CXCR4/genetics , Receptors, CXCR4/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism
5.
Angew Chem Int Ed Engl ; 54(44): 13095-100, 2015 Oct 26.
Article in English | MEDLINE | ID: mdl-26336938

ABSTRACT

The design of inhibitors of protein-protein interactions mediating amyloid self-assembly is a major challenge mainly due to the dynamic nature of the involved structures and interfaces. Interactions of amyloidogenic polypeptides with other proteins are important modulators of self-assembly. Here we present a hot-segment-linking approach to design a series of mimics of the IAPP cross-amyloid interaction surface with Aß (ISMs) as nanomolar inhibitors of amyloidogenesis and cytotoxicity of Aß, IAPP, or both polypeptides. The nature of the linker determines ISM structure and inhibitory function including both potency and target selectivity. Importantly, ISMs effectively suppress both self- and cross-seeded IAPP self-assembly. Our results provide a novel class of highly potent peptide leads for targeting protein aggregation in Alzheimer's disease, type 2 diabetes, or both diseases and a chemical approach to inhibit amyloid self-assembly and pathogenic interactions of other proteins as well.


Subject(s)
Amyloid beta-Peptides/antagonists & inhibitors , Drug Design , Islet Amyloid Polypeptide/pharmacology , Alzheimer Disease/metabolism , Amyloid beta-Peptides/chemistry , Amyloid beta-Peptides/metabolism , Diabetes Mellitus, Type 2/metabolism , Humans , Islet Amyloid Polypeptide/chemistry , Protein Aggregates/drug effects , Surface Properties
7.
Food Chem Toxicol ; 61: 3-8, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23279843

ABSTRACT

Elite athletes undergo heavy training programs throughout the year. The aim of the present study was to evaluate blood biomarkers of redox status, oxidative stress, inflammation and angiogenesis over the course of a competitive season in elite female water polo players. The biomarkers were evaluated in four distinct phases of an athletic season. It was found that the reduced glutathione (GSH) concentration was significantly increased, whereas catalase activity was decreased in erythrocytes in phases 3 and 4 compared to phase 2. Plasma concentration of thiobarbituric acid reactive substances (TBARS) was increased in phases 3 and 4 compared to phases 1 and 2, the concentration of protein carbonyls was increased in phase 4, and total antioxidant capacity (TAC) was decreased in phases 2 and 3. Plasma monocyte chemoattractant protein-1 (MCP-1) was decreased in phases 3 and 4; interleukin-10 (IL-10) was increased in phase 4, whereas no change was observed for adiponectin and endoglin. The findings of this study indicate that oxidative stress and inflammation varies over the season in elite female water polo athletes and this information might be used to apply remedies for optimizing athletic performance and accelerating training recovery.


Subject(s)
Antioxidants/metabolism , Athletes , Biomarkers/blood , Inflammation/metabolism , Neovascularization, Physiologic/physiology , Oxidative Stress , Adult , Catalase/blood , Chemokine CCL2/blood , Erythrocytes/metabolism , Exercise , Female , Glutathione/blood , Humans , Interleukin-10/blood , Nontherapeutic Human Experimentation , Thiobarbituric Acid Reactive Substances/metabolism , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...